Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study

HCV is associated with an increased risk of cardiovascular events (CV). Whether HCV clearance by direct-acting antivirals (DAA) reduces incident CV disease is poorly understood. We investigate whether HCV eradication reduces CV events.

Source: Atherosclerosis - January 19, 2020 Category: Cardiology Authors: Luigi Elio Adinolfi, Salvatore Petta, Anna Ludovica Fracanzani, Carmine Coppola, Vincenzo Narciso, Riccardo Nevola, Luca Rinaldi, Vincenza Calvaruso, Laura Staiano, Vito Di Marco, Aldo Marrone, Pia Clara Pafundi, Antonio Solano, Rosa Lombardi, Ferdinando Source Type: research